Understanding OUR Cytokine-Based Immunotherapy Candidates Our Motivation extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, especially for cancers where treatment method selections remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/muinmos-acquires-stake-in-add-towards-enhanced-kyc-kyb-in-africa/